Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details, blocking access to the IMMU-TARGET study information on ClinicalTrials.gov.
    Difference
    20%
    Check dated 2026-09-21T22:21:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    No additions or deletions are present in the provided data for the page. The content appears unchanged from the previously captured version.
    Difference
    0.1%
    Check dated 2026-09-14T18:46:18.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new revision tag indicating an update to the site version (v3.6.6) and the previous revision tag (v3.6.5) was removed.
    Difference
    0.1%
    Check dated 2026-08-31T18:16:59.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a platform-level update. No study content or user-facing details appear to be altered.
    Difference
    0.0%
    Check dated 2026-08-10T12:29:39.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.4, signaling a software update to the ClinicalTrials.gov page. This update is a backend/UI tweak and does not modify the study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:26:27.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3, signaling a current version of the page. This update appears to be a metadata/version bump without changes to the study details, locations, or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-07-05T13:34:06.000Z thumbnail image

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.